International AIDS Vaccine Initiative-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:International AIDS Vaccine Initiative - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014038
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. It also conducts policy analysis and performs vaccine trials and epidemiological research. IAVI’s product portfolio includes mRNA-NFL, BG505 Envelope, eOD Immunogen, AAV-PG9, AD26, MVA, protein and CDV replicating vector, among others. The organization partners with academic, industry and government organizations and clinical research center. It operates in South Africa, Kenya, India, the US, and the Netherlands. IAVI is headquartered in New York, the US.

International AIDS Vaccine Initiative – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
International AIDS Vaccine Partners with CureVac 10
IAVI, GlycoMimetics, And Glycosensors and Diagnostics Enter Into Agreement To Develop AIDS Vaccine 11
Lipoxen Extends Co-Development Agreement With IAVI 12
Licensing Agreements 13
Valneva Enters Into Licensing Agreement With International AIDS Vaccine Initiative For HIV Vaccine 13
DNAVEC Enters Into Licensing Agreement With International AIDS Vaccine Initiative For Prophylactic AIDS Vaccine 14
International AIDS Vaccine Initiative – Key Competitors 15
International AIDS Vaccine Initiative – Key Employees 16
International AIDS Vaccine Initiative – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 18
Product News 20
May 19, 2016: New HIV-Mimicking Particles That Trigger Immune Response Could Advance AIDS Vaccine Design 20
Mar 24, 2016: New findings in humans provide encouraging foundation for upcoming AIDS vaccine clinical trial 21
Jan 15, 2016: Study Provides Additional Insights for AIDS Vaccine Design 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Key Facts 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
International AIDS Vaccine Initiative, Deals By Therapy Area, 2011 to YTD 2017 8
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
International AIDS Vaccine Partners with CureVac 10
IAVI, GlycoMimetics, And Glycosensors and Diagnostics Enter Into Agreement To Develop AIDS Vaccine 11
Lipoxen Extends Co-Development Agreement With IAVI 12
Valneva Enters Into Licensing Agreement With International AIDS Vaccine Initiative For HIV Vaccine 13
DNAVEC Enters Into Licensing Agreement With International AIDS Vaccine Initiative For Prophylactic AIDS Vaccine 14
International AIDS Vaccine Initiative, Key Competitors 15
International AIDS Vaccine Initiative, Key Employees 16
International AIDS Vaccine Initiative, Other Locations 17

★海外企業調査レポート[International AIDS Vaccine Initiative-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amazon Web Services Inc:企業の戦略・SWOT・財務分析
    Amazon Web Services Inc - Strategy, SWOT and Corporate Finance Report Summary Amazon Web Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ygm Trading Ltd.
    Ygm Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ygm Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CareDx Inc (CDNA):医療機器:M&Aディール及び事業提携情報
    Summary CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used …
  • Worldpay Us Inc:企業の戦略・SWOT・財務分析
    Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report Summary Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PulteGroup Inc (PHM):企業の財務・戦略的SWOT分析
    PulteGroup Inc (PHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Baoviet Holdings
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Yanlord Land Group Ltd:企業の戦略・SWOT・財務情報
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kia Motors Corporation:企業の戦略・SWOT・財務情報
    Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Prime Capital AG-エネルギー分野:企業M&A・提携分析
    Summary Prime Capital AG (Prime Capital) is a financial service provider that offers asset management and professional services. The company provides infrastructure investments including renewable energy, private debt and hedge fund strategies through its independent asset management and advisory se …
  • Auspex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Auspex Pharmaceuticals Inc (Auspex), a subsidiary of Teva Pharmaceutical Industries Ltd is a biopharmaceutical company that develops and commercializes novel medicines for the treatment of movement disorders and other rare diseases including orphan diseases. The company offers products for t …
  • Del Frisco’s Restaurant Group, Inc.:企業の戦略・SWOT・財務情報
    Del Frisco’s Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Frisco’s Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Pearson plc:企業の戦略・SWOT・財務情報
    Pearson plc - Strategy, SWOT and Corporate Finance Report Summary Pearson plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Becle S.A.B. de C.V. (CUERVO) -Financial and Strategic SWOT Analysis Review
    Becle S.A.B. de C.V. (CUERVO) -Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Tenth Avenue Petroleum Corp (TPC):石油・ガス:M&Aディール及び事業提携情報
    Summary Tenth Avenue Petroleum Corp (TPC), formerly Jadela Oil Corp is an oil and gas company that explores and develops petroleum and natural gas properties in Western Canada. The company explores and develops Eagle Ford Shale in Eagle Pass of Maverick County, Texas. It operates an oilfield water d …
  • DeNA Co Ltd (2432):企業の財務・戦略的SWOT分析
    DeNA Co Ltd (2432) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Mtr Corporation Ltd:企業の戦略・SWOT・財務分析
    Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tektronix, Inc.:企業の戦略・SWOT・財務分析
    Tektronix, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tektronix, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • DCM Shriram Ltd (DCMSHRIRAM):企業の財務・戦略的SWOT分析
    Summary DCM Shriram Ltd (DSL), formerly DCM Shriram Consolidated Ltd is a chemical company that manufactures and distributes chlor-vinyl and agricultural products. The company’s agricultural products include urea and SSP fertilizers, sugar, hybrid seeds, and farm solutions. Its chlor-vinyl products …
  • Bauhaus International (Holdings) Limited (483):企業の財務・戦略的SWOT分析
    Bauhaus International (Holdings) Limited (483) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • MISC Berhad:企業の戦略・SWOT・財務分析
    MISC Berhad - Strategy, SWOT and Corporate Finance Report Summary MISC Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆